AbbVie Inc. is 2.6x more valuable than ABBOTT LABORATORIES by market capitalization ($399.47 B vs $154.72 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ABT | ABBV |
|---|---|---|
| Market cap | $154.72 B | $399.47 B |
| US-listed rank | #96 | #28 |
| Revenue (latest FY) | $44.33B | $61.16B |
| Net income (latest FY) | $6.52B | $4.23B |
| Net margin | 14.7% | 6.9% |
| P/E (trailing FY) | 23.7 | 94.5 |
| SEC filings | 1,001 | 1,008 |
AbbVie Inc. is 2.6x more valuable than ABBOTT LABORATORIES by market capitalization ($399.47 B vs $154.72 B).
In their latest fiscal years, ABBOTT LABORATORIES reported $44.33B in revenue while AbbVie Inc. reported $61.16B.
Full pages: ABBOTT LABORATORIES and AbbVie Inc., or browse the full rankings.